Meera Natarajan

Array ( [id] => 5760030 [patent_doc_number] => 20060210975 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-21 [patent_title] => 'Secreted and cytoplasmic tumor endothelial markers' [patent_app_type] => utility [patent_app_number] => 10/519805 [patent_app_country] => US [patent_app_date] => 2003-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17247 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0210/20060210975.pdf [firstpage_image] =>[orig_patent_app_number] => 10519805 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5760030 [patent_doc_number] => 20060210975 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-21 [patent_title] => 'Secreted and cytoplasmic tumor endothelial markers' [patent_app_type] => utility [patent_app_number] => 10/519805 [patent_app_country] => US [patent_app_date] => 2003-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17247 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0210/20060210975.pdf [firstpage_image] =>[orig_patent_app_number] => 10519805 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6951786 [patent_doc_number] => 20050226880 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-13 [patent_title] => 'Use of a preparation based on an antibody directed against a tumor-associated glycosylation' [patent_app_type] => utility [patent_app_number] => 10/519323 [patent_app_country] => US [patent_app_date] => 2003-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8008 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20050226880.pdf [firstpage_image] =>[orig_patent_app_number] => 10519323 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5800275 [patent_doc_number] => 20060035320 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-16 [patent_title] => 'Immunoglobulin frameworks which demonstrate enhanced statbility in the intracellular envioronment and methods of identifying same' [patent_app_type] => utility [patent_app_number] => 10/515241 [patent_app_country] => US [patent_app_date] => 2004-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 13091 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20060035320.pdf [firstpage_image] =>[orig_patent_app_number] => 10515241 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7004616 [patent_doc_number] => 20050169929 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-04 [patent_title] => 'Use of a vaccine for active immunization against cancer' [patent_app_type] => utility [patent_app_number] => 10/515146 [patent_app_country] => US [patent_app_date] => 2003-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6292 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0169/20050169929.pdf [firstpage_image] =>[orig_patent_app_number] => 10515146 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5710410 [patent_doc_number] => 20060051755 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-09 [patent_title] => 'Methods of assaying for cell cycle modulators' [patent_app_type] => utility [patent_app_number] => 10/510903 [patent_app_country] => US [patent_app_date] => 2003-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 91 [patent_figures_cnt] => 91 [patent_no_of_words] => 31891 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0051/20060051755.pdf [firstpage_image] =>[orig_patent_app_number] => 10510903 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6913176 [patent_doc_number] => 20050176934 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-11 [patent_title] => 'Antibody combination useful for tumor therapy' [patent_app_type] => utility [patent_app_number] => 10/510881 [patent_app_country] => US [patent_app_date] => 2003-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9186 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20050176934.pdf [firstpage_image] =>[orig_patent_app_number] => 10510881 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 581637 [patent_doc_number] => 07452965 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-11-18 [patent_title] => 'Colon tumor specific binding peptides' [patent_app_type] => utility [patent_app_number] => 10/510155 [patent_app_country] => US [patent_app_date] => 2003-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 11 [patent_no_of_words] => 7945 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/452/07452965.pdf [firstpage_image] =>[orig_patent_app_number] => 10510155 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7020373 [patent_doc_number] => 20050222392 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'Anti-idiotype anti-cea antibody molecules and its use as cancer vaccine' [patent_app_type] => utility [patent_app_number] => 10/510523 [patent_app_country] => US [patent_app_date] => 2003-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11918 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20050222392.pdf [firstpage_image] =>[orig_patent_app_number] => 10510523 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5710009 [patent_doc_number] => 20060051354 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-09 [patent_title] => 'Chemotherapeutic agents as anti-cancer vaccine adjuvants and therapeutic methods thereof' [patent_app_type] => utility [patent_app_number] => 10/508738 [patent_app_country] => US [patent_app_date] => 2003-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6701 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0051/20060051354.pdf [firstpage_image] =>[orig_patent_app_number] => 10508738 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6967328 [patent_doc_number] => 20050234225 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-20 [patent_title] => 'Human antibodies specific to kdr and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/506997 [patent_app_country] => US [patent_app_date] => 2003-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13923 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20050234225.pdf [firstpage_image] =>[orig_patent_app_number] => 10506997 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5776690 [patent_doc_number] => 20060105330 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-18 [patent_title] => 'Diagnostics and remedies for malignant brain tumor' [patent_app_type] => utility [patent_app_number] => 10/506382 [patent_app_country] => US [patent_app_date] => 2003-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 7790 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20060105330.pdf [firstpage_image] =>[orig_patent_app_number] => 10506382 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5923868 [patent_doc_number] => 20060241015 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-26 [patent_title] => 'Cancer genes' [patent_app_type] => utility [patent_app_number] => 10/502394 [patent_app_country] => US [patent_app_date] => 2003-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 54 [patent_figures_cnt] => 54 [patent_no_of_words] => 26092 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20060241015.pdf [firstpage_image] =>[orig_patent_app_number] => 10502394 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7675740 [patent_doc_number] => 20040126378 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-01 [patent_title] => 'Antibodies to treat cancer' [patent_app_type] => new [patent_app_number] => 10/317747 [patent_app_country] => US [patent_app_date] => 2002-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 20137 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0126/20040126378.pdf [firstpage_image] =>[orig_patent_app_number] => 10317747 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5912833 [patent_doc_number] => 20060127895 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-15 [patent_title] => 'Use of c-jun or c-jun activating agents such as uv or c-jun n-terminal kinases (junks) for treating cancer' [patent_app_type] => utility [patent_app_number] => 10/497564 [patent_app_country] => US [patent_app_date] => 2002-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 7258 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20060127895.pdf [firstpage_image] =>[orig_patent_app_number] => 10497564 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7163153 [patent_doc_number] => 20050085433 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-21 [patent_title] => 'Cellular vaccines comprising adjuvants' [patent_app_type] => utility [patent_app_number] => 10/494716 [patent_app_country] => US [patent_app_date] => 2002-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11033 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0085/20050085433.pdf [firstpage_image] =>[orig_patent_app_number] => 10494716 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 162502 [patent_doc_number] => 07671010 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-02 [patent_title] => 'Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer' [patent_app_type] => utility [patent_app_number] => 10/530168 [patent_app_country] => US [patent_app_date] => 2002-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 52778 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/671/07671010.pdf [firstpage_image] =>[orig_patent_app_number] => 10530168 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 581773 [patent_doc_number] => 07452976 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-11-18 [patent_title] => 'Biological products' [patent_app_type] => utility [patent_app_number] => 10/492228 [patent_app_country] => US [patent_app_date] => 2002-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 9963 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/452/07452976.pdf [firstpage_image] =>[orig_patent_app_number] => 10492228 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7599714 [patent_doc_number] => 07582733 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-01 [patent_title] => 'Humanized antibodies that recognize beta amyloid peptide' [patent_app_type] => utility [patent_app_number] => 10/232030 [patent_app_country] => US [patent_app_date] => 2002-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 39145 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 176 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/582/07582733.pdf [firstpage_image] =>[orig_patent_app_number] => 10232030 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6813208 [patent_doc_number] => 20030072758 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-17 [patent_title] => 'BMPR1A involvement in juvenile polyposis' [patent_app_type] => new [patent_app_number] => 10/153217 [patent_app_country] => US [patent_app_date] => 2002-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 32167 [patent_no_of_claims] => 76 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20030072758.pdf [firstpage_image] =>[orig_patent_app_number] => 10153217 [rel_patent_id] =>[rel_patent_doc_number] =>)